Konsulentfirmaet LG Pharma ApS: Financial statements 2024
CVR: 44845016
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Konsulentfirmaet LG Pharma ApS (CVR 44845016) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 768,170 and a net result of DKK 18,306. Equity in the 2024 report amounted to DKK 486,306. The solvency ratio was 59.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 768,170
- Profit/Loss
- DKK 18,306
- Equity
- DKK 486,306
- Total Assets
- DKK 820,455
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of May 15, 2024, Liselotte Gothenborg Schougaard is registered as director of Konsulentfirmaet LG Pharma ApS.
As of May 15, 2024, Liselotte Gothenborg Schougaard is registered as an owner of Konsulentfirmaet LG Pharma ApS with an ownership share of 100%.
Konsulentfirmaet LG Pharma ApS was founded on May 15, 2024.
About Konsulentfirmaet LG Pharma ApS
Konsulentfirmaet LG Pharma ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2024. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Liselotte Gothenborg Schougaard. The company is owned by Liselotte Gothenborg Schougaard. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 960,214 and a net result of DKK 160,802 compared with DKK 18,306 the year before. Equity in the 2025 report amounted to DKK 512,108.